Table 2 Baseline characteristics of study participants with Nephroprotection
Population/year | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
(n = 33,541) | (n = 33,541) | (n = 33,541) | (n = 33,541) | |
Mean Age (sd) | 63.89 (11.36) | 64.86 (11.34) | 65.8 (11.3) | 66.72 (11.25) |
Age group (%) | ||||
20 to24 | 45 (0.13%) | 40 (0.12%) | 28 (0.08%) | 16 (0.05%) |
25 to29 | 107 (0.32%) | 91 (0.27%) | 86 (0.26%) | 78 (0.23%) |
30 to34 | 218 (0.65%) | 179 (0.53%) | 144 (0.43%) | 116 (0.35%) |
35 to39 | 487 (1.45%) | 414 (1.23%) | 356 (1.06%) | 313 (0.93%) |
40 to44 | 881 (2.63%) | 799 (2.38%) | 724 (2.16%) | 630 (1.88%) |
45 to49 | 1,673 (4.99%) | 1,477 (4.40%) | 1,289 (3.84%) | 1,158 (3.45%) |
50 to54 | 3,069 (9.15%) | 2,788 (8.31%) | 2,514 (7.50%) | 2,202 (6.57%) |
55 to59 | 4,687 (13.97%) | 4,355 (12.98%) | 4,007 (11.95%) | 3,746 (11.17%) |
60 to64 | 5,811 (17.33%) | 5,684 (16.95%) | 5,534 (16.50%) | 5,308 (15.83%) |
65 to69 | 5,805 (17.31%) | 5,910 (17.62%) | 6,024 (17.96%) | 6,013 (17.93%) |
70 to74 | 4,718 (14.07%) | 4,978 (14.84%) | 5,168 (15.41%) | 5,475 (16.32%) |
75 to79 | 3,248 (9.68%) | 3,507 (10.46%) | 3,794 (11.31%) | 4,064 (12.12%) |
80 or More | 2,792 (8.32%) | 3,319 (9.90%) | 3,873 (11.55%) | 4,422 (13.18%) |
Sex (%) | ||||
Women | 19,033 (56.75%) | 19,033 (56.75%) | 19,035 (56.75%) | 19,039 (56.76%) |
Men | 14,508 (43.25%) | 14,508 (43.25%) | 14,506 (43.25%) | 14,502 (43.24%) |
Race (%) | ||||
Other | 32,992 (98.36%) | 33,260 (99.16%) | 33,261 (99.17%) | 33,256 (99.15%) |
Black | 549 (1.64%) | 281 (0.84%) | 280 (0.83%) | 285 (0.85%) |
Stage CKD (%) | ||||
Without CKD | 12,773 (38.08%) | 12,137 (36.19%) | 11,644 (34.72%) | 11,871 (35.39%) |
G1 | 673 (2.01%) | 658 (1.96%) | 690 (2.06%) | 643 (1.92%) |
G2 | 14,759 (44.00%) | 14,748 (43.97%) | 14,849 (44.27%) | 14,400 (42.93%) |
G3a | 3,539 (10.55%) | 3,802 (11.34%) | 3,883 (11.58%) | 3,948 (11.77%) |
G3b | 1,419 (4.23%) | 1,670 (4.98%) | 1,884 (5.62%) | 1,942 (5.79%) |
G4 | 378 (1.13%) | 526 (1.57%) | 591 (1.76%) | 737 (2.20%) |
State (%) | ||||
Controlled | 8,321 (24.81%) | 8,109 (24.18%) | 7,306 (21.78%) | 6,745 (20.11%) |
Death | 765 (2.28%) | 2,094 (6.24%) | 2,638 (7.87%) | 3,034 (9.05%) |
Uncontrolled | 24,455 (72.91%) | 23,338 (69.58%) | 23,597 (70.35%) | 23,762 (70.84%) |
Region (%) | ||||
Amazonía/Orinoquía | 655 (1.95%) | 655 (1.95%) | 651 (1.94%) | 651 (1.94%) |
Bogotá D.C | 7,147 (21.31%) | 7,389 (22.03%) | 7,149 (21.31%) | 7,031 (20.96%) |
Caribbean | 3,920 (11.69%) | 3,832 (11.42%) | 3,927 (11.71%) | 3,926 (11.71%) |
Central | 7,934 (23.65%) | 7,927 (23.63%) | 7,967 (23.75%) | 7,978 (23.79%) |
Eastern | 4,954 (14.77%) | 4,818 (14.36%) | 4,933 (14.71%) | 5,045 (15.04%) |
Pacific | 8,931 (26.63%) | 8,920 (26.59%) | 8,914 (26.58%) | 8,910 (26.56%) |